Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

TESLASCAN

MANGAFODIPIR TRISODIUM

Standard Dose
37.9MG/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TESLASCAN is listed in Drugs@FDA under application 020652 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MANGAFODIPIR TRISODIUM Form and strength INJECTABLE;INJECTION - 37.9MG/ML Sponsor IC TARGETS Submission history Latest submission status date: 2002-07-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview TESLASCAN is listed in Drugs@FDA under application 020652 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MANGAFODIPIR TRISODIUM Form and strength INJECTABLE;INJECTION - 37.9MG/ML Sponsor IC TARGETS Submission history Latest submission status date: 2002-07-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.